ARHS vs LUCK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARHS exhibits weak financial health per the Piotroski F-Score of 4/9, indicating marginal stability with notable red flags in profitability and liquidity. The company trades at a P/E of 14.79, below the sector average of 43.27, but this is misleading given a sharp -28.6% YoY earnings decline and negative Q/Q earnings growth. While the Graham Number ($5.66) suggests undervaluation, the intrinsic value estimate of $3.36 reflects poor growth prospects and deteriorating fundamentals. The lack of dividend, neutral insider activity, and prolonged price decline (down 42.6% over 5 years) further undermine confidence. Despite a recent analyst 'buy' recommendation, the underlying metrics suggest significant distress risk.
LUCK presents a high-risk profile characterized by a stable Piotroski F-Score (5/9) that masks severe underlying balance sheet distress. The company exhibits a negative Price-to-Book ratio (-2.84), indicating negative shareholder equity, and a critical liquidity shortage with a current ratio of 0.69. While analysts maintain a 'buy' rating with a target of $10.89, the fundamental data shows collapsing EPS growth (-250% YoY) and a completely unsustainable dividend payout ratio of 981.44%. The combination of a 0/100 technical trend and consistent earnings misses suggests a significant downward trajectory.
Compare Another Pair
Related Comparisons
ARHS vs LUCK: Head-to-Head Comparison
This page compares Arhaus, Inc. (ARHS) and Lucky Strike Entertainment Corporation (LUCK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.